Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the
The number of items prescribed in the UK’s private medical cannabis market has doubled each
Product Earth, the UK’s largest event celebrating cannabis and other natural medicines, has cancelled the
Landlords, property managers, and housing associations in the UK are currently at risk of breaching
Written by Releaf Releaf offers every patient at the clinic a medical cannabis card to
Introduction: The Life of a CAPEX Director As the Director of Capital Projects (CAPEX) for investors based in Geneva, my professional journey took me to Africa, South Asia, and the Middle East. My work involved extensive travel to various “hot spots,” which left me returning home to England only when possible. This lifestyle eventually took […]
The post From CAPEX Director to Cannabis Advocate: A Journey of Resilience and Healing appeared first on I Am Billy.
In what was thought to be a first for a major mainstream health conference on
A new animal study has highlighted the possible benefits of CBD and the diabetes drug,
Cannabis, once stigmatized and criminalized, has emerged as a powerful medicinal substance. With growing research and changing perceptions, the therapeutic potential of cannabis is becoming widely recognized. This blog explores the transformative role of cannabis in modern medicine, highlighting its benefits, applications, and the science behind its efficacy. A Brief History of Cannabis in Medicine […]
The post The Power of Cannabis as Medicine appeared first on I Am Billy.
Hi, my name is Andy Kent. I am an autistic, high-functioning individual who has faced numerous challenges and setbacks throughout my life. Although I no longer work, I previously held the position of an executive trainer chef, specializing in troubleshooting any kitchen within the Midlands and North UK. My career allowed me to work for […]
The post “On The Brink of Suicide: Health and Safety Issues in Private Prescription Cannabis Healthcare” appeared first on I Am Billy.
At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions –
Sales of legal cannabis in the USA are projected to reach $33 billion in 2024,
Ecstasy pills with higher than average levels of MDMA are currently being sold in the
Introduction Prescription cannabis patients often face subpar care while trying to navigate their new medicine. From doctors informing them that “product is out of stock” to pharmacists questioning, “What’s a COA?” (Certificate of Analysis), patients are left disheartened and frustrated. This blog explores the challenges faced by these patients and emphasizes the need for better […]
The post Navigating Prescription Cannabis appeared first on I Am Billy.
In this article, we explore the stigma associated with cannabis, the challenges faced by ethnic communities in the UK, and offer guidance for those seeking medical cannabis treatment.
The post Ethnic Diversity in Cannabis: Navigating Stigma and Health Challenges first appeared on PatientsCann UK.
A groundbreaking study by researchers at the Comprehensive Center for Pain & Addiction has highlighted the potential of cannabis terpenes to provide relief from chemotherapy-induced neuropathic pain. This study, published in the journal PAIN, suggests that terpenes from Cannabis sativa may be as effective as morphine in managing chronic pain, offering a promising alternative with […]
The post Cannabis Terpenes as Effective as Morphine for Pain Relief with Fewer Side Effects appeared first on I Am Billy.
Introduction A recent study has uncovered intriguing findings about the use of medical marijuana in treating depression and anxiety. The research, which included individuals diagnosed with clinical depression, revealed that those using medicinal cannabis reported lower depression scores compared to non-users. This blog delves into the study’s findings and discusses the implications for the treatment […]
The post Baltimore researchers find cannabis could be effective treatment Anxiety and Depressive Symtoms appeared first on I Am Billy.
Life Before Medicinal Cannabis My name is Antonín, and I am 41 years old. After an accident at work, I have been on a disability pension for the past ten years. For the last 17 years, I have lived in Scotland. My mother and father, along with my sister and brother and their families, reside […]
The post My Journey: From Disability to Wellness with Medicinal Cannabis appeared first on I Am Billy.
Medical cannabis cultivator Glass Pharms has officially delivered its first crop to the first UK-based
Introduction: A Landmark Achievement for Patient Care After six long years, UK patients can finally rejoice. Releaf has announced a significant breakthrough that promises to end the persistent supply issues that have plagued the therapeutic market. This development marks a new era in patient care, ensuring a reliable supply of essential medications. Ensuring Security of […]
The post UK Patients Have Been Waiting 6 Entire Years for This to Happen!! appeared first on I Am Billy.
A new refractory epilepsy treatment, containing THC, has been approved for use in the UK for the first time. A new cannabis treatment for refractory (or drug-resistant) epilepsy, containing THC, has been approved by the Medicine and Healthcare products Regulatory Agency (MHRA) for prescription for patients
Not feeling the Christmas cheer this year? We examine if CBD could help with some of the more difficult aspects of the season. Christmas isn’t always the most wonderful time of the year for everybody. It can be difficult to get through the season when you
Newly-published real-world evidence finds medical cannabis to be effective in managing symptoms of PTSD and comorbid depression. There has been increasing interest in using cannabis-based medicines in the treatment of PTSD, particularly in the veteran population. Most notably, Ukraine recently legalised medical cannabis with President Zelensky
In an extract taken from the Principles of Cannabinology Handbook, Viola Brugnatelli and Fabio Turco, explore the relationship between multiple sclerosis and medical cannabis. In the world of modern medicine, there is a growing interest in exploring alternative treatments for a wide range of ailments; one area
Via Business of Cannabis Spain’s newly appointed health minister has said that the country’s long-awaited medical cannabis law will be ready ‘in the coming months,’ as she makes good on her promise to kickstart progress. Mónica García Gómez used her first appearance in Congress to reaffirm
We bring you the news you might have missed from the week just gone. The top lines this week: Families say they have been failed by how access to medical cannabis has played out in the UK, while a new industry report calls for GP prescribing
Adults who consumed cannabis for a year did not show any reduction in working memory, reward, and inhibitory control brain function, a study has shown. The federally funded research, published by the American Medical Association in the journal JAMA Network Open, involved 57 patients who had been
Volteface and The Medical Cannabis Clinicians Society (MCCS) have today been appointed as the new secretariat for the UK’s medical cannabis All-Party Parliamentary Group (APPG). APPGs are informal cross-party groups that have no official status within Parliament, but seek to unite groups of MPs and peers
A company from Oklahoma, USA, hopes to enter the record books this Thursday 20th April when they unveil what they claim will be the largest cannabis infused chocolate bar the world has ever seen. Created by edibles brand Zen Cannabis, the giant confectionary named ‘The Big
A study, published in the Journal of Cannabis Research, has found that the legalisation of cannabis is linked with higher levels of physical activity. In the study, researchers from Brigham Young University used data from the Behavior Risk Factor Surveillance System (BRFSS) to evaluate the association between
A report published this week by The National Centre for Social Research (NatCen) has found that 80% of Generation Z support the legalisation of cannabis in the United Kingdom. The report, titled Society Watch 2024: Understanding the new generation of voters, provides insight into three key policy issues
On the 1st of November 2018, the UK government moved cannabis from Schedule 1 to Schedule 2 of the Misuse of Drugs Act 1971. While this might sound like a small change, this rescheduling actually allowed the medical prescription of cannabis-based products in the UK for
Caomihe Ni Drisceoil shares how she uses CBD, alongside other natural remedies, to help combat the pain from arthritis and migraines. Caoimhe Ni Drisceoil was diagnosed with arthritis when she was in her 50s. The pain began in her knees before moving to her hands and
In the regulated cannabis sector, retail shrinkage is a concern as business owners must navigate tight regulations in an often cash-only environment combined with the usual causes of retail shrinkage, including theft and inefficient operations. Retail shrinkage occurs when a company loses inventory from causes other
The first patient to receive medical cannabis flower through the NHS has shared how it helped him manage debilitating side-effects of cancer treatment. In April 2023, Mike Roberts secured the first NHS reimbursement for medical cannabis flower prescribed through a private clinic to manage chemotherapy-induced nausea
Written by Releaf To establish whether medical cannabis is the right option for you, you need to know whether it’s within your budget. Here, Releaf breaks down how much it all costs and the different plans available. Market research has shown that one of the most
Timothy Byars, director of Cannabis Programs at Pacific College of Health and Science in the US, explores what clinicians need to know when it comes to cannabis and potential drug interactions. There are currently 21 states, Washington DC, and Guam that have legalised adult-use cannabis. Four
A new study suggests cannabis could have a significant impact on quality of life for women living with fibromyalgia. A recently-published study suggests that early treatment with cannabis could improve quality of life for women with a diagnosis of fibromyalgia. The treatment was shown to improve
Dravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical treatment. It is estimated that one in 15,700 children will be diagnosed with the condition, most of which will experience seizures in their first year of life. The
At Curaleaf Clinic (formally Sapphire Clinics), we see patients with a range of conditions – such as chronic pain, post-traumatic stress disorder (PTSD) and anxiety. We also have a growing number of patients suffering from these conditions who are military veterans. With a special nod to
Cannabis has been used both recreationally and medicinally for thousands of years, yet the mechanisms through which cannabis compounds affect the human body remain relatively unclear. Many studies have indicated that cannabis may be helpful in the treatment of various medical conditions and illnesses. Cannabidiol –
New research has been released for patients with Fibromyalgia which has assessed the effects seen in UK patients after being prescribed medical cannabis. Symptoms commonly experienced in Fibromyalgia include anxiety, debilitating fatigue, chronic pain, sensitivity to light, sound, temperature and touch, as well as cognitive symptoms
Sapphire patient, Helen, and Dr James Rucker of Sapphire Medical Clinics spoke to Louise Eccles in The Sunday Times about the rising number of patients prescribed medical cannabis in the UK. Helen explained that “I had taken other medication for my anxiety previously but it gave
Medical cannabis has been available for prescription in the UK since November 2018, and since then an ever-growing number of patients have been able to access these medicines. Now, the UK has approved three vaporisers for the medical use of cannabis, offering specialists doctors the ability
Copyright © 2024 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
